Xeris Biopharma Holdings, Inc. (XERS) Financials

XERS Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 392.0 million 379.0 million
Dec. 31, 2025 383.5 million 369.8 million
Sept. 30, 2025 370.2 million 371.1 million
June 30, 2025 334.7 million 354.0 million

XERS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 9.5 million ?
Dec. 31, 2025 19.7 million 5.3 million
Sept. 30, 2025 18.1 million 7.6 million
June 30, 2025 -97000 5.0 million

XERS Net Income

No data available :(

XERS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 111.8 million 31.1 million -
Dec. 31, 2025 111.0 million 31.5 million 37.8 million
Sept. 30, 2025 91.6 million 32.0 million 38.2 million
June 30, 2025 59.3 million 218.6 million 38.6 million

XERS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 177.6 million
Dec. 31, 2025 180.1 million
Sept. 30, 2025 177.6 million
June 30, 2025 156.0 million

XERS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 325000 8.8 million 53.1 million -
Dec. 31, 2025 333000 7.9 million 47.5 million -
Sept. 30, 2025 363000 7.5 million 46.5 million -
June 30, 2025 279000 8.1 million 44.4 million -

XERS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 83.1 million 13.3 million
Dec. 31, 2025 85.8 million 19.1 million
Sept. 30, 2025 74.4 million 11.0 million
June 30, 2025 71.5 million 14.6 million

XERS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

XERS

Price: $6.88

52 week price:
4.30
10.08

Earnings Per Share: 0.07 USD

P/E Ratio: 91.86

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 485000

Market Capitalization: 1.1 billion

Links: